Remove COVID-19 Remove Licensing Remove Public Health Remove World Health
article thumbnail

COVID ‘Compromise’ on International IP Underscores Need for New Approach

Bill of Health

It only narrowly modifies compulsory licenses of patents covering COVID vaccines. Moreover, it imposes additional restrictions on use of compulsory licenses. IP on COVID vaccines should be a global public good. This is true not just for COVID, but future pandemics. We need a new approach. Data exclusivity.

COVID-19 309
article thumbnail

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

During large transnational public health crises, global demand soars for diagnostics, drugs, and vaccines. Consider, for instance, the case of COVID-19 vaccines. The first pathway is requiring funding recipients to use out-licensing to alleviate scarcity. Using Contracts to Further Equity Goals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Better Health Care Tests, Faster

Healthcare IT Today

Speeding up Test Development We’ve seen with COVID-19 how quickly a virus can evolve and how hard it is to design both tests and vaccinations that accommodate different variants. Virax Biolabs uses data from the World Health Organization and others to develop tests quickly.

COVID-19 103
article thumbnail

Where telemedicine is headed now that the PHE has ended

Healthcare IT News - Telehealth

The COVID-19 public health emergency came to an end on May 11. This also happens to coincide with the World Health Organization declaring an end to the COVID-19 global health emergency. What does the end of the public health emergency mean for the future of the healthcare industry?

article thumbnail

Reclaiming Global Public Health

Bill of Health

By December 2020, the world had astonishingly powerful tools against COVID-19. New mRNA vaccines, underpinned by decades of public investment , had been authorized by global regulators. The answer to one of the most important public health questions of our time — who gets access to vaccines? — By Zain Rizvi.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”

article thumbnail

A Blueprint for Solving the U.S. Nursing Shortage Crisis

HIT Consultant

NP-C, CSE Nurses have the highest level of public trust across medical professions, yet there’s a huge chasm between Americans’ appreciation for nursing and the profession’s uncertain future. A nursing shortage, exacerbated by the COVID pandemic, has been fueled largely by high levels of moral distress, politicization, and lack of support.

Nurses 98